Literature DB >> 11580771

Hemifacial seizure of cerebellar ganglioglioma origin: seizure control by tumor resection.

J H Chae1, S K Kim, K C Wang, K J Kim, Y S Hwang, B K Cho.   

Abstract

The cerebellum is known to have an inhibitory effect on seizures. Nevertheless, cerebellar dysplastic lesions can be epileptogenic. A 4-month-old infant had paroxysmal facial contractions; tachypnea and nystagmoid eyeball and tremulous movements were occasionally combined. These evolved to stereotypic clinical patterns and frequencies, which increased despite administration of antiepileptic drugs (AEDs). Magnetic resonance imaging (MRI) demonstrated a mass arising from the superior cerebellar peduncle, although video-scalp EEG monitoring revealed no abnormal findings. Positron emission tomography with [(18)F]fluorodeoxyglucose revealed focal hypermetabolism in the same area identified by MRI. A depth electrode implanted in the mass revealed focal spike-and-wave discharges. The lesion was partly removed; pathologic diagnosis was ganglioglioma. Because of incomplete seizure control and residual tumor visible on MRI, a second operation was performed. After complete excision of the tumor, the patient became seizure free without AEDs. This case confirms the presence of seizure originating from the cerebellum and emphasizes the need for the complete removal of an epileptogenic lesion.

Entities:  

Mesh:

Year:  2001        PMID: 11580771     DOI: 10.1046/j.1528-1157.2001.43398.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  17 in total

1.  Ganglioglioma in brainstem : case report and a review of literatures.

Authors:  Sung-Duk Kim; Jong Hyun Kim; Cheol-Young Lee; Hyun-Woo Kim
Journal:  J Korean Neurosurg Soc       Date:  2014-03-31

Review 2.  Fourth ventricle hamartoma presenting with progressive myoclonus and hemifacial spasms: case report and review of literature.

Authors:  Nelia Zamponi; Claudia Passamonti; Michele Luzi; Roberto Trignani; Luana Regnicolo; Marina Scarpelli
Journal:  Childs Nerv Syst       Date:  2011-04-06       Impact factor: 1.475

Review 3.  Facial spasms, but not hemifacial spasm: a case report and review of literature.

Authors:  Michael M McDowell; Xiao Zhu; Marion A Hughes; Raymond F Sekula
Journal:  Childs Nerv Syst       Date:  2016-03-16       Impact factor: 1.475

Review 4.  Pediatric infratentorial ganglioglioma.

Authors:  Stephanie Puget; Awad Alshehri; Kevin Beccaria; Thomas Blauwblomme; Giovanna Paternoster; Syril James; Federico Dirocco; Christelle Dufour; Michel Zerah; Pascale Varlet; Christian Sainte-Rose
Journal:  Childs Nerv Syst       Date:  2015-09-09       Impact factor: 1.475

Review 5.  Epilepsy in type 1 Chiari malformation.

Authors:  Tiziana Granata; Laura Grazia Valentini
Journal:  Neurol Sci       Date:  2011-12       Impact factor: 3.307

Review 6.  Infiltrative cerebellar ganglioglioma: conventional and advanced MRI, proton MR spectroscopic, and FDG PET findings in an 18-month-old child.

Authors:  U Löbel; D W Ellison; B L Shulkin; Z Patay
Journal:  Clin Radiol       Date:  2010-11-19       Impact factor: 2.350

7.  Chronic isolated hemifacial spasm as a manifestation of epilepsia partialis continua.

Authors:  Alberto J Espay; Vincent J Schmithorst; Jerzy P Szaflarski
Journal:  Epilepsy Behav       Date:  2007-10-24       Impact factor: 2.937

8.  Epilepsia partialis continua possibly caused by cerebellar lesion.

Authors:  Tatiana Vander; Mark Medvedovsky; Yuval Herishanu
Journal:  Cerebellum       Date:  2004       Impact factor: 3.847

9.  Posterior cranial fossa gangliogliomas.

Authors:  Sam Safavi-Abbasi; Federico Di Rocco; Kraisri Chantra; Guenther C Feigl; Amr El-Shawarby; Amir Samii; Madjid Samii
Journal:  Skull Base       Date:  2007-07

Review 10.  Lesional cerebellar epilepsy: a review of the evidence.

Authors:  Niels A Foit; Vera van Velthoven; Reinhard Schulz; Ingmar Blümcke; Horst Urbach; Friedrich G Woermann; Christian G Bien
Journal:  J Neurol       Date:  2016-06-03       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.